Healthcare News

Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 4 août au 5 août 2026       Nom de l'émetteurCode identifiant de l'émetteur (code LEI)Jour de...

Aggregated presentation by day and by market Weekly report on share repurchases from 04th August to 05th August 2026       Name of the IssuerIdentify code of the IssuerTransaction dayIdentify code of...

Company announcement no. 29 – 2610 August 2026 NTG Nordic Transport Group publishes interim report for H1 2026The interim report for H1 2026 is enclosed. In connection with publication of the...

Six new Genome BC supported projects use integrated genomic and health data to explore earlier diagnosis, personalized care and better outcomes.

Company announcement No. 37 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 32, 2026) Copenhagen, Denmark, August 10, 2026 – Zealand Pharma A/S ("the Company" or...

NeOnc Technologies (NASDAQ:NTHI) is scheduled to unveil topline Phase 2a results for NEO100 on Wednesday, August 12

No clinical safety or efficacy issues identified and no additional clinical or nonclinical data requestedThe Complete Response Letter for the ongoing ITM-11 New Drug Application (NDA) cites Chemistry,...

Bagsværd, Denmark, 10 August 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of...

BELTSVILLE, Md., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Xcellon Biologics, a U.S.-based Contract Research, Development and Manufacturing Organization (CRDMO) specializing in bioconjugates and complex...

Investigator-led study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ophthalmology Initial DREAM Study Results Anticipated in Q4 2026 SOLANA BEACH,...